GL1X · GenesisL1 explorer

MolNFT v1 · #52726 · protein

Structure of Fab fragment of the icsm 18 - anti-prp therapeutic antibody at 1.57 a resolution.

2W9D · Icsm 18-anti-prp therapeutic Fab heavy chain: “Structure of Fab fragment of the icsm 18 - anti-prp therapeutic antibody at 1.57 a resolution.”. X-ray diffraction, 1 ligand (CA), 4 pockets (best druggability 0.62). MolNFT v1 #52726…

PDB
2W9D
Type
protein
Length
426 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Icsm 18-anti-prp therapeutic Fab heavy chain; Icsm 18-anti-prp therapeutic Fab light chain
Ligands
CA
Pockets
4 · best druggability 0.62

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HIcsm 18-anti-prp therapeutic Fab heavy chainprotein2156% helix, 51% strand—
LIcsm 18-anti-prp therapeutic Fab light chainprotein2117% helix, 51% strand—

Ligands and binding sites

  • CA · Calcium ion · metal · chains H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15880.620.7466empty
21530.470.7724empty
3530.310.7616empty
4560.270.7416empty

Interfaces

1 interface between chains.

  • H–L · 1690 Ų buried · 17 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 modified (disulfide, cyclization).

Compared structures

  • 2W9D · Structure of Fab fragment of the ICSM 18 - anti-Prp therapeutic antibody at 1.57 A… · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.